GLPwatch

Obestatin promotes proliferation and survival of adult hippocampal progenitors and reduces amyloid-β-induced toxicity.

Mol Cell Endocrinol · 2016

Last updated 2026-05-28

In lab tests on rat brain cells, a peptide called obestatin helped cells grow and survive, even when growth factors were removed. Obestatin also reduced damage caused by a protein linked to Alzheimer’s disease, and its effects were blocked by a GLP-1 receptor drug, suggesting it may work through similar pathways.

AI summary of the abstract below.

JournalMol Cell Endocrinol, 2016
Citations18
Relative citation ratio0.77
NIH percentile41
Molecules
Conditions studied Alzheimers

Abstract

The ghrelin gene-derived peptide obestatin promotes survival in different cell types through a yet undefined receptor; however, its potential neuroprotective activities are still unknown. Here, obestatin effects were investigated on proliferation and survival of adult rat hippocampal progenitor cells (AHPs). Obestatin immunoreactivity was found in AHPs; moreover, obestatin binding to AHPs was displaced by the GLP-1R agonist Ex-4 and antagonist Ex-9. Furthermore, obestatin increased cell proliferation and survival in growth factor deprived medium and inhibited apoptosis; these effects were blocked by Ex-9. The underlying mechanisms involved Gαs/cAMP/PKA/CREB signaling, phosphorylation of ERK1/2 and PI3K/Akt, and the PI3K targets GSK-3β/β-catenin and mTOR. Obestatin also counteracted Aβ1-42-induced detrimental effects through inhibition of GSK-3β activity and Tau hyperphosphorylation, main hallmarks of neuronal death in Alzheimer's disease. These findings indicate a novel protective role for obestatin in AHPs and candidate this peptide as potential therapeutic target for increasing neurogenesis and for approaching neurodegenerative disorders.

Verbatim abstract via PubMed 26586206 ↗